Patients with advanced hepatocellular carcinoma (HCC) receiving atezolizumab-bevacizumab treatment were more likely to experience variceal bleeding if they had a low platelet count, main portal ...

One such treatment involves a combination of the drugs atezolizumab and bevacizumab, and is referred to as Atezo/Bev therapy.

Citing a Feb. 14 data cut, the Brisbane, California-based biotech said amezalpat led to a six-month survival advantage with cancer drugs atezolizumab and bevacizumab, marketed as Tecentriq and ...

Immunotherapy has revolutionised the treatment of advanced hepatocellular carcinoma, starting with atezolizumab–bevacizumab superseding sorafenib in the first line. But how have other areas of care ...

Patients with HCC at high risk of recurrence after resection or local ablation were randomly assigned to receive either atezolizumab plus bevacizumab or active surveillance in the IMbrave 050 study.

Othman T, Frankel P, Allen P, et al. Atezolizumab combined with immunogenic salvage chemoimmunotherapy in patients with transformed diffuse large B-cell lymphoma. Haematologica . 2025;110(1):142 ...

The panelist discusses, for intermediate-stage unresectable hepatocellular carcinoma (uHCC), key clinical pearls include ...

Tecentriq in combination with bevacizumab will help the 70 or so New Zealanders diagnosed with Hepatocellular Carcinoma (HCC) each year.

Following the PET-CT findings, surgical resection plans for two patients were altered to SIRT combined with atezolizumab plus bevacizumab; TACE plans for one patient changed to atezolizumab plus ...

By Simeon Brown, Member of Parliament for Pakuranga There’s been some good news from Pharmac this month. The agency has ...

(Journal of Hepatology) Real-world data showed that patients receiving atezolizumab (Tecentriq) plus bevacizumab for hepatocellular carcinoma (HCC) can still have good survival outcomes after ...

Atezolizumab (Tecentriq) + bevacizumab (Avastin) + chemotherapy for ovarian cancer TS ID 10701 Technology appraisal guidance TBC Atezolizumab as neoadjuvant (with chemotherapy) and adjuvant (as ...